LEADER 02945nam 2200625 450 001 9910479876803321 005 20200929132929.0 010 $a0-271-05369-0 010 $a0-271-05678-9 024 7 $a10.1515/9780271056784 035 $a(CKB)2670000000160087 035 $a(PromptCat)40019538367 035 $a(MH)012817344-0 035 $a(SSID)ssj0000688407 035 $a(PQKBManifestationID)11481496 035 $a(PQKBTitleCode)TC0000688407 035 $a(PQKBWorkID)10607364 035 $a(PQKB)10592770 035 $a(OCoLC)780531472 035 $a(MdBmJHUP)muse19815 035 $a(MiAaPQ)EBC6224117 035 $a(DE-B1597)583977 035 $a(DE-B1597)9780271056784 035 $a(EXLCZ)992670000000160087 100 $a20200929d2011 uy 0 101 0 $aeng 135 $aur|||||||nn|n 181 $ctxt 182 $cc 183 $acr 200 10$aDecentralization, democratization, and informal power in Mexico /$fAndrew Selee 210 1$aUniversity Park :$cPennsylvania State University Press,$d[2011] 210 4$d©2011 215 $a1 online resource (xi, 191 p. )$cill. ; 300 $aIncludes index. 311 $a0-271-04843-3 320 $aIncludes bibliographical references and index. 327 $tList of Figures --$tAcknowledgments --$g1.$tIntroduction: The Paradoxes of Local Empowerment --$gPart 1.$tState Formation and Political Change --$g2.$tCentralization and Informal Power --$g3.$tDecentralization and Democratization --$gPart 2.$tA Tale of Three Cities --$g4.$tChilpancingo: The Continuation of Corporatism? --$g5.$tTijuana: Liberal Democracy? --$g6.$tCiudad Nezahualcóyotl: Social Movement Democracy? --$gPart 3.$tConclusions --$g7.$tPathways of Democratic Change --$tIndex. 330 $a"Explores the democratization and decentralization of governance in Mexico and finds that informal political networks continue to mediate citizens' relationships with their elected authorities. Analyzes the linkages between informal and formal power by comparing how they worked in three Mexican cities: Tijuana, Ciudad Nezahualco?yotl, and Chilpancingo"--Provided by publisher. 606 $aDemocracy$zMexico 606 $aDecentralization in government$zMexico 607 $aMexico$xPolitics and government 608 $aElectronic books. 615 0$aDemocracy 615 0$aDecentralization in government 676 $a320.972 700 $aSelee$b Andrew D.$01026873 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910479876803321 996 $aDecentralization, democratization, and informal power in Mexico$92442023 997 $aUNINA 999 $aThis Record contains information from the Harvard Library Bibliographic Dataset, which is provided by the Harvard Library under its Bibliographic Dataset Use Terms and includes data made available by, among others the Library of Congress LEADER 03593nam 22005654a 450 001 9910831053403321 005 20230616235809.0 010 $a1-280-19728-5 010 $a9786610197286 010 $a0-470-79102-0 010 $a0-470-99471-1 010 $a1-4051-4097-6 035 $a(CKB)1000000000351278 035 $a(EBL)233111 035 $a(OCoLC)437147415 035 $a(SSID)ssj0000150751 035 $a(PQKBManifestationID)11162908 035 $a(PQKBTitleCode)TC0000150751 035 $a(PQKBWorkID)10281330 035 $a(PQKB)11450239 035 $a(MiAaPQ)EBC233111 035 $a(EXLCZ)991000000000351278 100 $a20040608d2004 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEvaluating pharmaceuticals for health policy and reimbursement$b[electronic resource] /$fedited by Nick Freemantle and Suzanne Hill 210 $aMalden, Mass. $cBMJ Books/Blackwell Pub.$d2004 215 $a1 online resource (280 p.) 300 $aDescription based upon print version of record. 311 $a0-7279-1784-6 320 $aIncludes bibliographical references and index. 327 $aDevelopment of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit Ra?go -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] -- 327 $aRelationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.]. 330 $a"The challenge in all settings is to make the difficult decisions in a way that is defensible, justifiable, ethical, and equitable" So write Nick Freemantle and Suzanne Hill in their introduction to this important discussion on decision making in the reimbursement of pharmaceuticals. Based around a programme supported by the World Health Organization, chapters by leading academics involved in the research tackle such major issues as international pharmaceutical policy, tensions in licensing policies, priority setting, and relationships between the stakeholders. 606 $aPharmaceutical policy 615 0$aPharmaceutical policy. 676 $a362.17/82 676 $a362.1782 701 $aFreemantle$b Nick$0983439 701 $aHill$b Suzanne$0877980 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910831053403321 996 $aEvaluating pharmaceuticals for health policy and reimbursement$92245004 997 $aUNINA